NeuBase Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NeuBase Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2023.
  • NeuBase Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 6, 2023 was 3.73M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 3.73M Nov 6, 2023 10-Q 2023-11-09
Q2 2023 33.8M +1.55M +4.81% May 26, 2023 10-QT 2023-06-05
Q1 2023 33.8M +1.55M +4.81% May 8, 2023 10-Q 2023-05-11
Q4 2022 33M +283K +0.86% Dec 16, 2022 10-K 2022-12-21
Q2 2022 32.3M -458K -1.4% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 32.3M -458K -1.4% May 6, 2022 10-Q 2022-05-12
Q4 2021 32.7M +9.55M +41.2% Dec 15, 2021 10-K 2021-12-23
Q2 2021 32.7M +9.59M +41.5% Aug 11, 2021 10-Q 2021-08-13
Q1 2021 32.7M +15.6M +91.5% May 12, 2021 10-Q 2021-05-14
Q4 2020 23.2M +6.1M +35.7% Dec 21, 2020 10-K 2020-12-23
Q2 2020 23.1M +6.05M +35.5% Aug 12, 2020 10-Q 2020-08-13
Q1 2020 17.1M +14.3M +504% Mar 25, 2020 10-Q 2020-03-26
Q4 2019 17.1M -39.4M -69.8% Jan 7, 2020 10-K 2020-01-10
Q2 2019 17.1M -39.4M -69.8% Aug 14, 2019 10-Q 2019-08-14
Q1 2019 2.83M -53.6M -95% May 13, 2019 10-Q 2019-05-15
Q4 2018 56.5M +270K +0.48% Jan 2, 2019 10-K 2019-01-03
Q2 2018 56.5M +255K +0.45% Aug 14, 2018 10-Q 2018-08-14
Q1 2018 56.5M +255K +0.45% May 15, 2018 10-Q 2018-05-15
Q4 2017 56.2M +20.2M +56.3% Dec 13, 2017 10-K 2017-12-15
Q2 2017 56.2M +24.1M +75.1% Aug 7, 2017 10-Q 2017-08-08
Q1 2017 56.2M +24.7M +78.5% May 9, 2017 10-Q 2017-05-11
Q4 2016 36M +5.63M +18.6% Dec 20, 2016 10-K 2016-12-22
Q2 2016 32.1M +1.77M +5.84% Aug 8, 2016 10-Q 2016-08-09
Q1 2016 31.5M +1.17M +3.84% May 8, 2016 10-Q 2016-05-10
Q4 2015 30.3M +5.07M +20.1% Dec 14, 2015 10-K 2015-12-14
Q2 2015 30.3M Aug 6, 2015 10-Q 2015-08-06
Q1 2015 30.3M +6.71M +28.4% May 11, 2015 10-Q 2015-05-11
Q4 2014 25.3M +5.29M +26.5% Dec 22, 2014 10-K 2014-12-22
Q3 2014 24.9M Aug 18, 2014 10-Q 2014-08-18
Q1 2014 23.6M -26.1M -52.5% May 12, 2014 10-Q 2014-05-13
Q4 2013 20M -27.7M -58.1% Dec 27, 2013 10-K 2013-12-27
Q2 2013 19.7M -27.5M -58.3% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 49.7M +7.99M +19.1% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 47.7M 0 0% Dec 31, 2012 10-Q 2013-02-19
Q3 2012 15.8M -23.9M -60.3% Sep 30, 2012 10-Q 2013-08-13
Q2 2012 47.1M Jun 30, 2012 10-Q 2012-08-07
Q1 2012 41.7M May 11, 2012 10-Q 2012-05-11
Q4 2011 47.7M Jan 3, 2012 10-K 2013-01-09
Q3 2011 39.7M Sep 30, 2011 10-K 2013-01-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.